Pegylated Interferon Lambda Treatment for COVID-19

Summary

Prospective randomized trial to assess the antiviral efficacy of Pegylated Interferon Lambda (180 mcg SC injection) vs.placebo in up to 20 subjects with COVID-19 infection.

Timeline

Start

2020-06-22

Primary completion

2021-07-30

Completion

2021-07-30

Publications

• Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.

Drugs

Indications